Hip replacement is often thought of as a procedure reserved for later in life. Many younger patients carry this assumption into their first consultation, particularly those who have spent years managing juvenile arthritis or another inflammatory condition that has accelerated joint damage well ahead of the typical timeline.
In reality, age is not the primary factor in determining whether hip replacement is necessary. The extent of joint damage is. For patients with inflammatory arthritis, that damage can occur decades earlier than expected, making surgery a consideration far sooner than most people anticipate.
Understanding this distinction is an important first step for younger patients evaluating their options. Here is what you should know before making this decision.
Inflammatory Arthritis Is Not the Same as Wear-and-Tear
Most people associate hip replacement with older adults whose joints simply wore out over time. Inflammatory arthritis works differently. Conditions like rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and juvenile idiopathic arthritis (JIA) involve an immune response that actively attacks joint tissue. Cartilage breaks down not from mechanical overuse but from chronic inflammation, and the damage can be severe and widespread by the time a patient is in their 30s or 40s.
This distinction matters when evaluating candidacy for surgery. The conversation is not about whether a younger patient is "too young." It is about whether continued non-surgical management is still offering meaningful quality of life.
When Conservative Treatment Is No Longer Enough
Biologics, corticosteroids, and disease-modifying antirheumatic drugs (DMARDs) can slow inflammatory arthritis significantly and delay joint damage for many patients. But for some, medication reaches its limits. When hip pain disrupts sleep, limits walking distance, prevents basic daily activities, and no longer responds adequately to medication or injections, joint replacement becomes a serious conversation.
Orthopedic evaluation at this stage helps clarify the degree of structural damage and whether the remaining joint architecture can support continued conservative care.
Why Surgical Approach Can Matter in Younger Patients
Younger patients tend to be more active, recover differently, and will live with their implant for longer than an older patient would. These factors make surgical technique especially consequential.
The Direct Anterior Approach (DAA) to hip replacement is particularly well-suited for younger and more active patients. By working between muscle planes rather than cutting through them, the anterior approach avoids detaching major muscle groups from the hip. The result is less early post-operative pain, faster functional recovery, and a lower dislocation risk in the early weeks, when younger patients are often most eager to resume normal movement.
For patients with a history of inflammatory arthritis, where surrounding soft tissue may already be compromised from years of disease activity, a muscle-sparing approach offers additional benefit.
What to Expect Long-Term as a Younger Hip Replacement Patient
Implant longevity is a legitimate concern for patients in their 30s and 40s. Modern implants and bearing surfaces have improved substantially, and many patients in this age group can expect their primary replacement to last 20 or more years. Revision surgery remains a possibility over a long lifetime, which is why choosing a surgeon experienced in both primary and revision hip reconstruction matters from the outset.
Ongoing rheumatologic care continues after surgery. Hip replacement addresses structural damage but does not treat the underlying inflammatory disease. Coordination between your orthopedic surgeon and rheumatologist is essential both before and after the procedure.
If you are managing inflammatory arthritis and beginning to wonder whether your hip has reached a point where surgery deserves a serious look, a consultation with a hip reconstruction specialist can give you an honest picture of where things stand. Dr. Johnson welcomes patients from across Oklahoma City, Ardmore, and beyond, including those traveling from out of state for complex or revision cases.
Frequently Asked Questions
1. Can you get a hip replacement in your 30s or 40s?
Yes. Age alone does not determine candidacy for hip replacement. Surgeons evaluate the degree of joint damage, functional limitations, and how well a patient has responded to non-surgical treatment. Younger patients with significant joint destruction from inflammatory arthritis can be strong candidates.
2. Is hip replacement safe for patients with rheumatoid arthritis or juvenile arthritis?
Hip replacement is performed regularly in patients with rheumatoid arthritis and juvenile idiopathic arthritis. These patients require coordinated care between their rheumatologist and orthopedic surgeon, particularly around managing biologic medications before and after surgery, but outcomes are generally very good.
3. What is the Direct Anterior Approach and why does it matter for younger patients?
The Direct Anterior Approach accesses the hip joint through a natural gap between muscles rather than cutting through them. For younger, more active patients, this typically means a faster recovery, less early pain, and a lower early dislocation risk. It also preserves soft tissue integrity, which is meaningful for patients whose tissue may already be affected by years of inflammatory disease.
4. How long does a hip replacement last in a 35 or 40 year old patient?
Modern hip implants and bearing surfaces are designed for durability. Many patients who receive hip replacement in their 30s or 40s can expect their implant to function well for 20 or more years. Revision surgery may eventually be needed over a long lifetime, which makes choosing a surgeon experienced in revision reconstruction an important part of the initial decision.
5. Do I need to stop my biologic medication before hip replacement surgery?
Most biologic medications used to treat inflammatory arthritis are paused before surgery to reduce infection risk, since they suppress immune function. The specific timing depends on which medication you take and your rheumatologist's guidance. Your surgical team will coordinate with your rheumatologist to establish a safe pre- and post-operative medication protocol.
Reference Links:
AUTHOR: Dr. Nick R. Johnson, MD – Fellowship-Trained Orthopedic Surgeon
Dr. Nick R. Johnson, MD, is a fellowship-trained orthopedic surgeon specializing in hip and knee reconstruction, including complex primary and revision joint replacement. A native of Oklahoma, Dr. Johnson combines advanced surgical expertise with a compassionate, patient-centered approach to care. With specialized training in adult reconstruction and the management of periprosthetic joint infections, he is dedicated to delivering personalized treatment plans that restore mobility, relieve pain, and improve long-term outcomes.
Credentials & Recognition
Dr. Johnson earned his Bachelor of Science in Biomedical Studies and Doctor of Medicine from the University of Oklahoma. During medical school, he was selected for a prestigious Orthopedic Research Fellowship at the Mayo Clinic, where he trained under leading experts in the field. He completed his orthopedic surgery residency at Carolinas Medical Center in Charlotte, North Carolina, followed by a fellowship in Adult Reconstruction at OrthoCarolina. His advanced training focused on complex hip and knee replacement, revision surgery, and infection management.
Dr. Johnson is a member of the American Academy of Orthopaedic Surgeons (AAOS) and the American Association of Hip and Knee Surgeons (AAHKS), as well as Alpha Omega Alpha (AOA), a national medical honor society recognizing excellence in scholarship, leadership, and professionalism. His academic and clinical achievements reflect a strong commitment to advancing orthopedic care and maintaining the highest standards in patient outcomes.
Clinical Expertise
Dr. Johnson specializes in primary and revision hip and knee replacement, complex joint reconstruction, and the treatment of periprosthetic joint infections. He is particularly skilled in managing challenging cases and developing individualized surgical strategies tailored to each patient’s unique anatomy and needs.
Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice. For diagnosis and treatment recommendations, please consult with Dr. Johnson.